Stuttering Treatment and Research Society (STARS)

Gerald Maguire, MD, discusses the direct implications for diagnosis and prescribing in psychiatry.

STARS experts redefine stuttering as a brain-based neuropsychiatric disorder, urging interdisciplinary care and warning dopamine-boosting ADHD or antidepressant meds may worsen symptoms.

Thomas J. Valente, MD, explains the need for evidence-based guidelines for stuttering and says psychiatrists can help lead care, reduce stigma, and improve support for patients.

Gus Alva, MD, shares the importance of proper recognition of stuttering among patients.

During STARS' international expert consensus meeting, experts discuss the treatment implications of psychiatric comorbidity and stuttering.

Gerald Maguire, MD, discusses the unmet needs of patients with comorbid ADHD and stuttering.

From APSARD 2026, a patient journey demonstrates opportunities in psychiatric education on stuttering and emerging treatment approaches.

Gerald A. Maguire, MD, explores the importance of understanding stuttering in psychiatry, emphasizing the need for research, collaborative care, and awareness.

Half of patients with stuttering also experience anxiety, highlighting the psychiatrist’s role in care and support.

Because stuttering represents a spectrum disorder, a spectrum of treatments are needed.